IOPIDINE 1 % m/V, eye drop solution 2 single-dose containers of 0.25 ml
Active ingredients: Apraclonidine, Apraclonidine hydrochloride
Commercialized according to BDPMDispensing in France: Prescription only
Eye drop solution2 single-dose containers of 0.25 mlophtalmique
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- IOPIDINE 1 % m/V, collyre en solution
- Pharmaceutical form
- collyre en solution
- Route of administration
- ophtalmique
- Presentation description
- 2 récipient(s) unidose(s) polyéthylène basse densité (PEBD) de 0,25 ml suremballée(s)/surpochée(s)
- Marketing authorisation holder
- ESSENTIAL PHARMA (M) (MALTE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 22 May 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63218293CIP73410543CIP133400934105432Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE D'APRACLONIDINEcollyre | — | SA |
| APRACLONIDINEcollyre | 10 mg · 1 ml de solution | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.